Lifting and Tightening of the Face and Neck Following an Increased Density Treatment

Skin Laxity Clinical Trial

Official title:

Evaluation of the Efficacy and Safety of the Ulthera® System for Lifting and Tightening of the Face and Neck Following an Increased Density Treatment.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01519206
• Other study ID #: ULT-124
• Status: Completed
• Phase: N/A
• First received: December 8, 2011
• Last updated: November 10, 2017
• Start date: August 2011
• Est. completion date: March 2013

Study information

• Verified date: November 2017
• Source: Merz North America, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the Ulthera® System for obtaining lift and tightening of the cheek tissue, reduction of jowling, and improving jawline definition and/or submental skin laxity when increased density treatment is applied.

Description:

All enrolled study subjects will receive one full face and neck Ultherapy™ treatment. Pre- and post-treatment photos will be taken. Subjects will be required to return for follow-up visits at 60 days, 90 days, 180 days and 1 year following treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: March 2013
• Est. primary completion date: February 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 30 Years to 65 Years

Eligibility

Inclusion Criteria:

• Male or female, aged 30 to 65 years

• Subject in good health

• Desires lift and tightening of cheek tissue, reduction of jowling, improvement of jawline definition and/or submental skin laxity

• Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the followup period

• Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study

Exclusion Criteria:

• Presence of an active systemic or local skin disease that may affect wound healing

• Severe solar elastosis

• Excessive subcutaneous fat on the cheeks

• Excessive skin laxity on the lower face and neck

• Significant scarring in areas to be treated

• Significant open facial wounds or lesions

• Severe or cystic acne on the face

• Presence of a metal stent or implant in the facial area to be treated, a pacemaker, or cochlear implants

Related Conditions & MeSH terms

• Cutis Laxa
• Skin Laxity

Intervention

Device:
• Ulthera System Treatment
Focused ultrasound energy delivered below the surface of the skin.

Locations

Country	Name	City	State
United States	Laser & Skin Surgery Center of NY	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Ulthera, Inc

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement in Overall Lifting and Tightening of Skin	Improvement in overall lifting and tightening of skin was completed by three masked assessors, completing a qualitative assessment of pre- and post-treatment photographs. Masked photo pairs of pre/post treatment photos of each treated subject were provided to each assessor. Each photo pair was consistent in lighting, position, focus. The visit interval of each photo was NOT marked. Each assessor's review was completed independently, with no input from others, assessing the photos for improvement. If improvement was seen, the blinded assessor was to choose the post-treatment photo. Categories of assessment included Improved, No Change, or Incorrect post-treatment photo chosen. The majority assessment among the 3 blinded assessors for each subject was reported.	Baseline to 90 days post treatment
Secondary	Overall Aesthetic Improvement at 60 Days, 90 Days, 180 Days and 1 Year Post-treatment.	Improvement was assessed based on Global Aesthetic Improvement Scale (GAIS) scores. The GAIS was completed based on a live assessment of the subject and a photographic assessment comparing post-treatment photos to baseline photos. The PGAIS was completed by a clinician assessor; SGAIS was completed by the study subject. The GAIS is a 5-point scale (1-5) describing an overall assessment as follows: - Very Much Improved; - Much Improved; - Improved; - No Change; - Worse	Baseline to 60 days, 90 days, 180 days and 1 year post-treatment
Secondary	Subjects' Assessment of Pain	Subjects' sensory response to the Ulthera treatment exposures were recorded for each anatomical region treated using a validated Numeric Rating Scale (0-10), with 1 representing no pain and 10 representing the worst pain possible. Subjects rated pain for each transducer, in each treatment region. For statistical analyses, NRS scores were averaged for each transducer depth.	During Ulthera treatment
Secondary	Subject Satisfaction at 90 Days, 180 Days and 1 Year Post-treatment	Subject satisfaction was determined by scores on a patient satisfaction questionnaire (PSQ) completed at 90 days, 180 days and 1 year post-treatment. Subjects indicated how satisfied they were with their study treatment, i.e., Very Satisfied, Satisfied, Dissatisfied, Very Dissatisfied. Pre-treatment and post-treatment photographs were available for viewing at each follow-up visit interval. Subjects also had a mirror available for real time assessment, comparing their image in the mirror with pre-treatment and post-treatment photos.	Baseline to 90 days, 180 days and 1 year post-treatment